[{"Assets_0_Q1_USD":34834000000.0,"CommonStockDividendsPerShareDeclared_1_Q1_USD":0.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":1390000000.0,"NetIncomeLossConverted_1_Q1_USD":1715000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":1637000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1634000000.0,"StockholdersEquity_0_Q1_USD":15218000000.0,"StockholdersEquityConverted_0_Q1_USD":15317000000.0,"EarningsPerShareBasic_1_Q1_USD":1.05,"EarningsPerShareDiluted_1_Q1_USD":1.04,"RevenuesConverted_1_Q1_USD":5920000000.0,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20190425"}]